Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
08/24/2011 | EP2359701A1 Composition for improving membrane composition and functioning of cells |
08/24/2011 | EP2358740A1 Cyclic peptides and uses thereof |
08/24/2011 | EP2358739A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor |
08/24/2011 | EP2358725A1 Imidazolothiazole compounds as modulators of protein kinase |
08/24/2011 | EP2358704A1 7-azaspiro [3.5]nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase |
08/24/2011 | EP2358692A1 Cysteine protease inhibitors |
08/24/2011 | EP2358388A1 Pharmaceutical product for up-dosing of allergy vaccine |
08/24/2011 | EP2358383A1 Hiv/siv vaccines for the generation of mucosal and systemic immunity |
08/24/2011 | EP1829887B1 Cpg single-strand deoxynucleotides for use as adjuvant |
08/24/2011 | EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
08/24/2011 | EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
08/24/2011 | EP1259544B1 Heterologous polypeptide of the tnf family |
08/24/2011 | EP1023067B2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
08/24/2011 | CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides |
08/24/2011 | CN102164942A Triterpenoid compounds and methods of use thereof |
08/24/2011 | CN102164940A TGR5 modulators and methods of use thereof |
08/24/2011 | CN102164920A Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
08/24/2011 | CN102164917A Compounds which selectively modulate the CB2 receptor |
08/24/2011 | CN102164916A Compounds which selectively modulate the CB2 receptor |
08/24/2011 | CN102164904A 6-substituted isoflavonoid compounds and uses thereof |
08/24/2011 | CN102164902A 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
08/24/2011 | CN102164891A Substituted 1,2,3,4- tetrahydrocyclopenta[b]indol-3-yl) acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
08/24/2011 | CN102164604A Fused heterocyclic compounds useful as kinase modulators |
08/24/2011 | CN102164595A Nutritional support of the immune system during anti-cancer treatment |
08/24/2011 | CN102161998A Deoxyribonucleic acid (DNA) vaccine based on B7-1-PE40KDEL exotoxin fusion gene and application thereof |
08/24/2011 | CN102161962A Deer antler blood wine and production process thereof |
08/24/2011 | CN102161961A Health-care wine and preparation method thereof |
08/24/2011 | CN102161644A Ligands for g-protein coupled receptors |
08/24/2011 | CN101810766B Chinese medicinal composition and preparation method and application thereof |
08/24/2011 | CN101744915B Medicament for treating maternal-fetal ABO incompatibility |
08/24/2011 | CN101708247B Compound antivirus immune intensifier of Chinese herbal medicine |
08/24/2011 | CN101549042B Method for extracting amino acid from potatoes and application of extract thereof |
08/24/2011 | CN101472580B Therapeutic or prophylactic agent for allergic dermatitis |
08/24/2011 | CN101428124B Preparation method of plaster for strongly improving phylactic power |
08/24/2011 | CN101220091B Yao horsefly salivary gland immunoregulation peptide, gene and application thereof |
08/24/2011 | CN101098892B Antibodies against IL-13 receptor alpha 1 and uses thereof |
08/24/2011 | CN101081834B Process for the preparation of leukotriene antagonists |
08/24/2011 | CN101015312B Health care functional tea for conditioning subhealthy state |
08/23/2011 | USRE42645 Nutritional or therapeutic compositions and methods to increase bodily glutathione levels |
08/23/2011 | US8003791 Boronic ester and acid compounds, synthesis and uses |
08/23/2011 | US8003772 Chimeric PUFA polyketide synthase systems and uses thereof |
08/23/2011 | US8003688 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
08/23/2011 | US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
08/23/2011 | US8003608 Using small molecule amino acid derivatives |
08/23/2011 | US8003382 Nucleic acid molecules encoding a house dust mite allergen Der f VII, and antigenic peptides thereof |
08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
08/23/2011 | US8003115 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
08/23/2011 | US8003101 Inflammatory mediator antagonists |
08/23/2011 | US8003092 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
08/23/2011 | CA2483162C Use of 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino benzo[b]thiophene-2-carboxylic acid derivatives as il-4 inhibitors |
08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
08/23/2011 | CA2368218C Oat extracts: refining, compositions and methods of use |
08/23/2011 | CA2270877C Peptide-based immunotherapeutic agent |
08/23/2011 | CA2270176C Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus |
08/23/2011 | CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
08/18/2011 | WO2011100460A2 Ccr7 ligand delivery and co-delivery in immunotherapy |
08/18/2011 | WO2011100455A1 Inhibition of antibody responses to foreign proteins |
08/18/2011 | WO2011100359A1 Cannabinoid agonists |
08/18/2011 | WO2011100324A1 Cannabinoid receptor agonists |
08/18/2011 | WO2011100295A2 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase |
08/18/2011 | WO2011099875A1 Use of lactic acid bacteria to treat or prevent rhinitis |
08/18/2011 | WO2011099783A9 Method for producing cell growth factors from adipose-derived stem cells and monocytes and applications thereof |
08/18/2011 | WO2011099783A2 Method for producing cell growth factors from adipose-derived stem cells and monocytes and applications thereof |
08/18/2011 | WO2011099576A1 Aptamer to fgf2 and use thereof |
08/18/2011 | WO2011099514A1 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism |
08/18/2011 | WO2011099502A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf) |
08/18/2011 | WO2011098990A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases |
08/18/2011 | WO2011098652A1 Applications of the protein muns and the derivates thereof |
08/18/2011 | WO2011098569A1 Process for producing an allergen extract |
08/18/2011 | WO2011098452A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate |
08/18/2011 | WO2011098035A1 Sinomenine derivatives, synthetic methods and uses thereof |
08/18/2011 | WO2011097797A1 Polyphenol acrylic acid derivative, preparation and use in preparing medicine thereof |
08/18/2011 | WO2011097733A1 Free hexasaccharide isolated from several campylobacter species |
08/18/2011 | WO2011097708A1 Lipidated antigens and use thereof for enhancing an immunological response |
08/18/2011 | WO2011079249A3 Vitamin d glycosides and sulfates for treating diseases |
08/18/2011 | WO2011068953A9 Atoxic recombinant holotoxins of clostridium difficile as immunogens |
08/18/2011 | WO2011019932A3 Compositions and methods for the therapy and diagnosis of influenza |
08/18/2011 | US20110201986 Method for enhancing immune responses in mammals |
08/18/2011 | US20110201676 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
08/18/2011 | US20110201672 Semi-soft c-class immunostimulatory oligonucleotides |
08/18/2011 | US20110201654 Therapeutic combination |
08/18/2011 | US20110201651 Mitotic kinesin inhibitors and methods of use thereof |
08/18/2011 | US20110201643 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
08/18/2011 | US20110201641 Indole derivatives as crth2 receptor antagonists |
08/18/2011 | US20110201639 Stabilized tacrolimus composition |
08/18/2011 | US20110201625 Organic Comopunds |
08/18/2011 | US20110201619 Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic Disorders |
08/18/2011 | US20110201611 Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |
08/18/2011 | US20110201610 Aryl sulfonamides |
08/18/2011 | US20110201606 Pyrimidine derivatives |
08/18/2011 | US20110201599 CDK Modulators |
08/18/2011 | US20110201593 Tricyclic heterocyclic compounds, compositions and methods of use thereof |
08/18/2011 | US20110201589 New bradykinin b1 antagonists |
08/18/2011 | US20110201587 Hsp90 inhibitors and methods of use |
08/18/2011 | US20110201574 Fatty acid amide hydrolase inhibitors |
08/18/2011 | US20110201555 Novel estrogen receptor ligands |
08/18/2011 | US20110201115 Method and apparatus for production of a skin graft and the graft produced thereby |